GWN Securities’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
+4,372
New +$188K 0.04% 472
2025
Q3
– Sell
-5,142
Closed -$356K – 420
2025
Q2
$356K Sell
5,142
-1,914
-27% -$130K 0.07% 272
2025
Q1
$468K Buy
7,056
+3,964
+128% +$327K 0.03% 475
2024
Q4
$268K Buy
+3,092
New +$334K 0.07% 266

Other funds holding NVO

GWN Securities's NVO Position: Q2 2026 in Review

GWN Securities opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,372 shares worth $210K. The stake represents 0.04% of the portfolio and ranks #472 among its holdings. This is a return to the name: GWN Securities previously reported a position in NVO as recently as Q2 2025.

GWN Securities first reported a position in NVO in Q4 2024 and has held it in 4 quarters since. The position peaked at $468K in Q1 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • GWN Securities held 4,372 shares of Novo Nordisk worth $210K as of Q2 2026.
  • Novo Nordisk was a new GWN Securities position in Q2 2026.
  • Novo Nordisk made up 0.04% of GWN Securities's portfolio in Q2 2026, its #472 holding.
  • GWN Securities first reported a position in Novo Nordisk in Q4 2024 and has held it in 4 quarters since.
  • GWN Securities's Novo Nordisk position peaked at $468K in Q1 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.